Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecamylamine versus scopolamine anticholinergic challenge crossover study
NL-OMON37435Not yet recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Apr 2012
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mecamylamine and scopolamine in Alzheimer's disease (AD) and confusion (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Pharmacokinetics of mecamylamine and scopolamine, Adaptive tracking and 12 more. Planned start Apr 2012; status: not yet recruiting.
02
Drugs
mecamylaminescopolamine
03
Conditions
Alzheimer's disease (AD)confusion
Beyond the preview
Go deeper on NL-OMON37435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37435.